Clinical Trial Update: ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery) [Phase 4]

View source ↗

Summary

ANG-First is a Phase 4 trial assessing angiotensin II as first-line vasopressor therapy in patients undergoing cardiac surgery with vasodilatory hypotension, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-associated Vasodilatory Hypotension

Drugs mentioned

• Giapreza (Angiotensin II)

Snippet

Sponsor: University of Maryland St. Joseph Medical Center | Conditions: Vasodilatory Hypotension During or After Cardiac Surgery | Phase 4 | Status: RECRUITING